We are on an urgent mission to discover treatment for children affected by KIF1A Associated Neurological Disorder (KAND). Our team works rapidly to care for those diagnosed with mutations in KIF1A, and to accelerate vital research powered to find treatment for children living with KAND before time runs out.
Currently there are no approved treatments and no cure for KIF1A Associated Neurological Disorder, and the only relief for families is symptomatic. The goal of our research is to better understand the KIF1A gene, find treatment and ultimately cure the disorder.
KIF1A.ORG is the only group funding critical research. Our path to treatment is clear and we must act fast. The progressive nature of this neurodegenerative disorder has us racing against time to bring treatment to children living with KAND. We need your help.
KIF1A research is rapidly underway at the Chung Lab for Human Genetics and Precision Medicine at Columbia University. You can help KIF1A parents continue to power this life-saving research by making a donation to KIF1A.ORG.
Learn about our most recent findings about the KIF1A gene, its variants and mutations.
The first research study on KIF1A was completed in 2011. Review past research studies to get a background on the gene and associated disorders.
Natural History Study
The best way to learn about a new disorder is to compile a robust directory of those who have been diagnosed. This allows us to compare cases and find variations and similarities among them. Our Natural History Study does just that. Learn about the directory of people who have been diagnosed with KAND, how their symptoms and experiences overlap and what the data has taught us about the disorder.
Families who participate in the study are a key part in advancing research for a cure of KAND.